Skip to content

Clinical trials

Completed Phase 3 Neuromuscular Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuromuscular Diseases Phase: Phase 3 Status: Completed Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20132
20152
20171
20181
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Intermountain Health Care, Inc.2
PTC Therapeutics2
Baxalta now part of Shire1
Catabasis Pharmaceuticals1
Scholar Rock, Inc.1
Tonix Pharmaceuticals, Inc.1
University of Rochester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuromuscular Diseases9
Musculoskeletal Diseases6
Muscular Dystrophies4
Muscular Dystrophy, Duchenne4
Nervous System Diseases4
Muscular Diseases3
Genetic Diseases, Inborn2
Genetic Diseases, X-Linked2
Intervertebral Disc Displacement2
Muscular Disorders, Atrophic2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.